New children’s formulary
July 8, 2010
MIMS Australia, in conjunction
with The Royal Children’s Hospital
in Melbourne has developed the
newest World Health Organization
(WHO) Model Formulary for
Children.
Based on the second Essential
Medicines List for Children, and the
latest clinical evidence, the new
Formulary covers a total of 310
medications.
As the first-ever worldwide
standardised information
compilation, the Formulary
provides healthcare professionals
with information on the individual
medications, as well as their correct
use and dosage.
The Formulary also includes
detailed information on the
medicines’ dosage, adverse effects
and contraindications of these
medicines for use in children.
Unlike former Formulary
incarnations, developed by
individual parties and countries, the
WHO model provides one single
comprehensive guide to using
medicines in children for all
countries.
“MIMS was proud to be able to
provide the editorial review and
prepare the publication for print”
said Margaret Gehrig, National
Business Manager for MIMS.
“Partnering with the RCH and
WHO and helping to prepare such
important information that will
enable medical practitioners,
especially in developing countries,
to be better informed on
medication administration has been
a great experience,” she added.
Having spent countless hours
sourcing and preparing all the
clinical information for each of the
310 medications, The Royal
Children’s Hospital in Melbourne
welcomed the project’s completion,
with RCH Director of Pharmacy, Dr
Brian Lilley, saying: “Working on
such a key project that will improve
the treatment of children around
the world has been rewarding and
exciting.”
The above article was sent to subscribers in Pharmacy Daily's issue from 08 Jul 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Jul 10
